Who’s Hired? Teva’s Head In Israel Departs
As Former Teva Canada Head Takes On A New Role
Teva’s country head for its local Israeli operation has moved on, with Teva promoting his successor from within. Meanwhile, Doug Sommerville, the former head of Teva Canada, has taken a new role dedicated to efforts to tackle the accelerating COVID-19 crisis.
You may also be interested in...
Coherus BioSciences enjoyed another strong quarter, “exceeding expectations,” management said, as the US-based player revealed where it would invest its cash pile following a round of financing in April.
Three ANDA sponsors – HEC’s Sunshine Lake, Sigmapharm and Unichem – for generic versions of Eliquis had elected to take their Hatch-Waxman case to trial but were soundly beaten by originator’s Bristol-Myers Squibb and Pfizer. A launch in 2031 could now be their best, and only, option.
Perrigo management provided colorful commentary on Perrigo’s latest endeavors to separate the company’s US generics business, following the recent sale of Perrigo’s Rosemont Pharmaceuticals subsidiary for an “attractive” multiple.